Analystreport

Corcept Therapeutics Incorporated (NASDAQ: CORT) had its "hold" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $14.00 price target on the stock.

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors